R
R. Byhardt
Researcher at Veterans Health Administration
Publications - 27
Citations - 2554
R. Byhardt is an academic researcher from Veterans Health Administration. The author has contributed to research in topics: Radiation therapy & Carcinoma. The author has an hindex of 15, co-authored 27 publications receiving 2528 citations. Previous affiliations of R. Byhardt include Medical College of Wisconsin & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Radiation Therapy Oncology Group (RTOG) 88–08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
William T. Sause,Charles Scott,Samuel G. Taylor,David H. Johnson,Robert B. Livingston,Ritsuko Komaki,Bahman Emami,Walter J. Curran,R. Byhardt,Andrew T. Turrisi,A. Rashid Dar,James D. Cox +11 more
TL;DR: In "good-risk" patients with surgically unresectable non-small-cell lung cancer, induction chemotherapy followed by irradiation was superior to hyperfractionated radiation therapy or standard radiation therapy alone, yielding a statistically significant short-term survival advantage.
Journal ArticleDOI
Final Results of Phase III Trial in Regionally Advanced Unresectable Non-Small Cell Lung Cancer : Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group
William T. Sause,Patricia Kolesar,Samuel Taylor,David H. Johnson,Robert B. Livingston,Ritsuko Komaki,Bahman Emami,Walter J. Curran,R. Byhardt,A. Rashid Dar,Andrew T. Turrisi +10 more
TL;DR: Overall survival was statistically superior for the patients receiving chemotherapy and radiation vs the other two arms of the study, and the twice-daily radiation therapy arm, although better, was not statistically superior in survival for those patients receiving standard radiation.
Journal ArticleDOI
Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410
Walter J. Curran,Charles B. Scott,Corey J. Langer,R.U. Komaki,Jangsoon Lee,Stephen L. Hauser,Benjamin Movsas,Todd H. Wasserman,Anthony H. Russell,R. Byhardt,William T. Sause,James D. Cox +11 more
Journal ArticleDOI
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer
William T. Sause,Patricia Kolesar,Samuel G. Taylor,David H. Johnson,Robert B. Livingston,R.U. Komaki,Bahman Emami,Walter J. Curran,R. Byhardt,R Dar,Andrew T. Turrisi +10 more
TL;DR: Overall survival was statistically superior for the patients receiving chemotherapy and radiation vs the other two arms of the study, and the twice-daily radiation therapy arm, although better, was not statistically superior in survival for those patients receiving standard radiation.
Journal ArticleDOI
RTOG protocol 92-02: A phase III trial of the use of long term total androgen suppression following neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate
Gerald E. Hanks,J.D Lu,Mitchell Machtay,Varagur Venkatesan,Wayne H. Pinover,R. Byhardt,Seth A. Rosenthal +6 more